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Abstract: Antimicrobial resistance has become one of the greatest threats to global health. Over
80% of antibiotics are prescribed in primary care, with many prescriptions considered to be issued
inappropriately. The aim of this study was to examine the association between prescribing rates and
demographic, practice, geographic, and socioeconomic characteristics using a multilevel modelling
approach. Antibiotic prescribing data by 320 GP surgeries in Northern Ireland were obtained from
Business Services Organisation for the years 2014–2020. A linear mixed-effects model was used
to identify factors influencing antibiotic prescribing rates. Overall, the number of antibacterial
prescriptions decreased by 26.2%, from 1,564,707 items in 2014 to 1,155,323 items in 2020. Lower
levels of antibiotic prescribing were associated with urban practices (p < 0.001) and practices in less
deprived areas (p = 0.005). The overall decrease in antibacterial drug prescriptions over time was
larger in less deprived areas (p = 0.03). Higher prescribing rates were linked to GP practices located
in areas with a higher percentage of the population aged ≥65 (p < 0.001) and <15 years (p < 0.001).
There were also significant regional differences in antibiotic prescribing. We advocate that any future
antibiotic prescribing targets should account for local factors.
Keywords: antibiotics prescribing; antibacterial drugs; antimicrobial resistance; deprivation; primary
care; general practice; multilevel modelling; mixed-effects model
1. Introduction
Antimicrobial resistance (AMR), identified by the World Health Organisation as one
of the top global public health threats, is largely driven by excessive and inappropriate
prescribing [1]. Increased AMR not only endangers the efficacy of antibiotics but also
leads to infection-related complications, prolonged illness, higher hospitalisation rates,
and increased mortality [2]. By 2050, the global cost associated with AMR is predicted to
amount to $100 trillion in lost GDP and account for up to 10 million extra deaths a year [3].
The European Centre for Disease Prevention and Control estimated that approximately
33,000 patients in Europe die each year due to antibiotic-resistant infections [4]. In the UK,
antibiotic resistance can cause up to 12,000 deaths per year [3].
To address the threat posed by AMR in the UK, the first fully integrated five-year
strategy for tackling AMR was published in 2013 to address the actions needed in key
AMR areas including infection prevention and control, prescribing practice, education
and public engagement, development of treatment and technologies, surveillance, and
research [4]. One of its main objectives was to reduce the levels of inappropriate antimi-
crobial prescribing by 50% by 2020 [5]. The delivery of key components of this five-year
national action plan was supported by the establishment of the English Surveillance Pro-
gramme for Antimicrobial Utilisation and Resistance (ESPAUR) focusing on enhancing the
surveillance of antimicrobial resistance, monitoring antibiotic prescribing, and supporting
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interventions aimed at improving prescribing process [6]. These actions resulted in an
overall 9% reduction in antibiotic consumption in primary and secondary care over the
period 2014–2018 [7]. Building on the achievements of the 2013–2018 AMR strategy, the
UK’s 2019–2024 AMR National Action plan set the new, ambitious targets to further reduce
antibiotic use and improve diagnostic support for appropriate prescription [8]. In Northern
Ireland (NI), the Department of Health (previously the Department of Health, Social Ser-
vices and Public Safety) published in 2012 a five-year Strategy for Tackling Antimicrobial
Resistance (STAR) [9]. One of the outputs of this initiative was the publication of annual
reports on surveillance of antimicrobial use and resistance. Furthermore, in 2019, the NI
Department of Health announced the five-year action plan, complimenting the UK Action
Plan, and outlining the NI’s specific contribution to containing and controlling AMR [10].
Concerns about AMR resulted in increased monitoring and evaluation of antibiotic
prescribing, mainly in primary care. It is estimated that over 80% of all antibiotics are
prescribed by general practitioners (GPs) [11] and inappropriate prescribing in primary
care may account for 8.8–23% of all prescriptions [12]. Several studies investigated the
impact of different demographic, geographic, socioeconomic, and psychological factors
on prescribing rates [13–18]. It has been demonstrated that antibiotic prescribing was
associated with GP practice setting and a higher proportion of patients with long-term
conditions [17]. In addition, antibiotic prescribing was found to be higher in more deprived
areas in England [13], Scotland [14], and Wales [15]. For instance, Covvey at al. [14]
showed that the overall antibiotic prescription rates were 36.5% higher in the most deprived
(Scottish Index of Multiple Deprivation) SIMD quintile, compared to the least deprived
quintile. In fact, antibiotic prescribing rates were shown to be rising in the most deprived
areas [13]. Other factors related to higher prescribing rates included greater GP practice size
and households with lower income [17,18]. Furthermore, significant between-GP practice
variation in prescribing was attributed to GPs characteristics and other factors related to
the professional care-delivery system of antibiotics [19]. Higher antibiotic prescribing rates
were reported among older clinicians [18], male [20], non-UK qualified [20], and those
professionally involved with drug company representatives [21].
This is the first study to provide a comprehensive longitudinal analysis of antibiotics pre-
scribing in Northern Ireland primary care using a multilevel modelling approach. Specifically,
we aim to (1) evaluate temporal changes in antibiotic prescription; (2) identify the extent of
between-GP variations in antibiotic prescribing; and (3) examine the impact of demographic,
geographic, socioeconomic, and practice characteristics on antibiotic prescribing.
2. Materials and Methods
2.1. Study Design
This was a retrospective cohort study of antibiotic prescribing using routinely collected
primary care prescribing data.
2.2. Setting
NHS primary care in Northern Ireland was the setting, including general practices
(n = 320) that were operational throughout the study period, with antibiotic prescriptions
dispensed from January 2014 to December 2020. Accordingly, 31 practices that closed and
1 practice that opened during the period under review were excluded from the analysis.
2.3. Antibiotic Prescribing Data
Individual-level primary care prescribing data were obtained from the Business Ser-
vices Organisation (BSO) prescribing and dispensing information systems [22]. The dataset
includes openly accessible prescribing data from the monthly files published by BSO, which
contain information on total number of items prescribed by GPs or other non-medical pre-
scribers within GP practices (e.g., nurses) in NI. Antibacterial drugs were identified using
British National Formulary (BNF) codes, namely, chapter 5.1.
Antibiotics 2022, 11, 17 3 of 11
2.4. Factors Associated with Antibiotic Prescribing
A number of factors, previously shown to be associated with variation in prescribing,
were selected from publicly available data. These variables were: deprivation, GP prac-
tice size (the number of registered patients), Local Commissioning Group (LCG), setting
(urban/rural), patient demographics, and household income. Given that deprivation and
patient demographics were not available at the GP practice level, we used the aggregate
data collated at the super output area (SOA) level for the practice postcode. SOAs are
geographical areas designed for the publication of the Census outputs. As such, area-level
deprivation was assigned to each GP practice by linking the SOA code of a GP practice’s
postal address and the NI Multiple Deprivation Measure (MDM) rank [23]. The MDM rank
consists of seven distinct component domains, namely, (i) income deprivation, (ii) employ-
ment deprivation, (iii) health deprivation and disability, (iv) education, skills and training
deprivation, (v) proximity to services, (vi) living environment and (vii) crime and disor-
der [23]. The MDM provides a mechanism for ranking the 890 SOAs in NI from the most
deprived (rank 1) to the least deprived (rank 890). Demographic data at the SOA level were
obtained from the Mid-Year NI-Level Population Estimates [24]. We specifically extracted
the proportion of SOA population aged >65 years and <15 years given that previous studies
reported the association between level of antibiotic prescribing and percentage of older and
younger patients registered with a GP [17]. We also included in the analysis the proportion
of the population aged ≥65 and <15 living in households whose equivalised income was
<60% of the NI median. The urban/rural nature of the GP practice was determined using
the Northern Ireland Neighbourhood Information Service (NINIS) [25]. Accordingly, 85 GP
practices were categorised as rural and 235 as urban. Furthermore, each practice was
located within LCGs, which, in Northern Ireland, covers the same geographical area as
Health and Social Care (HSC) Trusts. Figures for the GP practice size were obtained from
the BSO Family Practitioner Services (2018–2020) [26] and the NI Council for Voluntary
Action (2014–2017) [27].
2.5. Statistical Analysis
To allow temporal and between-GP practice analysis of changes in antibiotic pre-
scribing, the standardised antibiotic prescribing rate (per 1000 patients) was calculated by
dividing the total number of antibacterial drugs (‘items’) prescribed in each year by the
total number of registered patients. The descriptive statistics, including median (interquar-
tile range [IQR]) were provided for each time point. The Shapiro–Wilk test was used to
determine if the data deviate from a normal distribution.
Given that our research design was based on the repeated-measures data for individual
GP practices that were organised in nested levels (clusters), the descriptive analyses were
complemented by performing the multilevel modelling analysis. The implementation of
a multilevel modelling approach is a suitable choice for studies with the same outcome
variable, which is repeatedly measured over time in the same study subjects (here, GP
practices). Note that such repeatedly measured data are not independent. Many statistical
techniques for analysing longitudinal data assume independence of the measurements.
However, repeated measurements taken from the same individual (such as, GP practice) are
often correlated, and hence, not independent. By not taking into account this correlation,
we can obtain biased estimates and invalid p-values. The use of multilevel modelling,
specifically a linear mixed-effects model, in our study allowed us not only to accommodate
nonindependence of repeated measurements but also draw subject-specific conclusions.
We first evaluated the appropriateness of using our multilevel modelling approach by
testing an “unconditional model” including only the dependent variable (i.e., standardised
antibiotic prescription rates) and the grouping variable (i.e., GP practice). Note that no
predictor variables were entered at this stage. The unconditional model revealed signif-
icant between-GP practice variation (p < 0.05), hence supporting the case for multilevel
modelling [28]. Since the use of multilevel model was appropriate, the following predictor
variables were added to the model: time, MDM rank, LCG, the urban/rural nature of the
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GP practice, GP practice size, the percentage of the population aged ≥65 and <15 years, and
the proportion of the population aged ≥65 and <15 living in households whose equivalised
income was <60% of the NI median. Next, we performed the variable selection based on
p-value-based stepwise deletion [28], with Akaike information criterion (AIC) chosen as
the optimal model selection approach [29]. The final model included the effect of time,
MDM rank, LCG, rurality, GP practice size, the percentage of the population aged ≥65
and <15 years, as well as the interaction term between time and: (i) LCG; (ii) MDM rank;
(iii) the percentage of the population aged ≥65; and (iv) the urban/rural nature of the GP
practice as fixed effects. Features that did not significantly improve model fit, including
the proportion of the population aged ≥65 and <15 living in households whose equiv-
alised income was <60% of the NI median as well as the interaction terms between other
covariates and time were excluded from the analysis. Random intercepts were modelled
for each GP practice. We confirmed that the addition of a random intercept significantly
improved model fit (p < 0.001). Maximum likelihood estimates were obtained using the
Nelder–Mead method. Data management was performed using Python, version 3.6.9, with
analysis carried out using R, version 3.6.3.
3. Results
3.1. Temporal Changes and Between-Practice Variation in Antibiotic Prescribing
A total of 10,165,296 antibiotic prescription items were dispensed in primary care over
the 7 year study period. The total number of antibiotic prescriptions and the number of
registered patients together with the year-on-year percentage change are shown in Table 1.
The number of antibacterial prescriptions (‘items’) dropped by 26.2%, from 1,564,707 items
in 2014 to 1,155,323 items in 2020. The largest decrease of 18.7% in the number of prescribed
items was observed between 2019 and 2020. This substantial decrease may in part be
explained by the COVID-19 pandemic, which resulted in citizens staying at home more
(and therefore being less exposed to infectious diseases other than COVID-19) and the
decrease in GP appointments. From March 2020, the majority of GP surgeries in Northern
Ireland ceased face to face appointments and moved to video or telephone consultations
in an effort to minimise the risk of spread of infection to both patients and staff. It has
been shown that the average number of GP appointments per week in Northern Ireland
decreased by 19%, from 432 appointments per week in 2019 to 348 appointments per week
in 2020 [30]. Girvan et al. [31] concluded that fewer GP appointments during the first
wave of COVID-19 resulted in an overall reduction in antibacterial prescribing of 5.49%
compared with the same period the previous year. The number of patients registered in
the 320 GP practices grew over the period under observation, from 1,855,949 in 2014 to
1,999,095 in 2020, an increase of 9.3%.
Table 1. Total prescriptions and the number of patients registered with a GP, with year-on-year
percentage change.
Year Prescriptions % Change inPrescriptions Registered Patients
% Change in
Registered Patients
2014 1,564,707 - 1,855,949 -
2015 1,536,909 −1.8 1,873,675 1.0
2016 1,562,211 1.6 1,902,438 1.5
2017 1,485,830 4.9 1,926,107 1.2
2018 1,438,796 −3.2 1,953,334 1.4
2019 1,421,520 −1.2 1,982,733 1.5
2020 1,155,323 −18.7 1,999,095 0.8
Total 10,165,296
Figure 1 shows the trends and between-GP practice variation in the standardised
number of antibiotic drugs (per 1000 patients). Although the general trend is downward,
we can still observe extensive between-practice variation. Overall, the average standardised
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prescribing rate decreased from 843 items/1000 patients in 2014 to 578 items/1000 patients
in 2020.
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Figure 2A s t changes in the standardised number of prescriptions for an-
tibiotic classes wit the average annual prescribing rate >20 prescriptions per 1000 pa-
tients. The three most common antibiotic classes, namely penicillins, macrolides, tetra-
cyclines, reported a decrease in the standardised number of prescriptions over the stu y
period, 40.0% (from 442.4 items/1000 patients in 2014 to 265.4 items/1000 patients in
2020), 45.4% ( 4.2 items/1000 patients in 2014 to 56.9 items/1000 patients in 2020), and
8.9% (97.0 items/1000 patients in 2014 to 88.4 items/100 patients in 2020), respectively.
Furthermore, there was a 22.2% decrease in prescribing rates for cephal sporins and other
beta-lactams (from 4 .1 items/1000 patients in 2014 to 31.2 items/1000 patie ts in 20 0),
and a 24.2% d crease in prescribing rates for ulphonamides and tri ethopri (from
85.3 items/1000 patients in 2014 to 64.6 items/1000 patients in 2020). The standardised
number of prescriptions for urinary-tract infection drugs increased from 44.2 items/1000 pa-
tients in 2014 to 47.1 items/1000 patients in 2020 (an increase of 6.4%). Figure 2B presents
the changes in the standardised number of prescriptions for seven antibiotic classes with
the average annual prescribing rate <20 prescriptions per 1000 patients. Three of these
classes reported a decrease in the standardised number of prescriptions over the study pe-
riod, namely, antituberculosis drugs (a reduction of 13.78%); metronidazole, tinidazole and
ornidazole (a reduction of 21.72%); and quinolones (a reduction of 47.75%). The increase in
prescription rates was observed for aminoglycosides (24.24%), clindamycin and lincomycin
(20.21%), antileprotic drugs (14.88%), and some other antibacterials including glycopeptide
antibacterials, fidaxomicin, linezolid, polymixins, and rifaximin (51.33%). Supplementary
materials: Table S1 provides the standardised number of prescriptions by antibiotic class in
the period 2014–2020
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3.2. Factors Influencing Antibiotic Prescribing
Chang s in ta dardised antibiotic prescribing rates were further evaluated using
a linear mixed-effects model with a random intercept for each GP practice. We ob-
served a substantial decrease in prescribing rates over time (β = −40.3, p < 0.001), i.e.,
for every one-year increase, the standardised number of prescribed drugs decreased by
40.3 items/1000 patients. On average, urban practices prescribed antibiotics less than rural
practices (β = −65.4, p < 0.001). Practices located in areas with a lower level of deprivation
(indicated by a higher score on the MDM Rank) were associated with a lower level of
prescribing (β = −0.1, p = 0.005). A higher percentage of the population aged ≥65 years
was associated with higher rates of prescribing (β = 9.9, p < 0.001), i.e., for one percentage
increase in the proportion of the population aged ≥65, we observed the 9.9 items/1000 pa-
tients increase in the standardised number of antibacterial drugs. A higher percentage of
the population aged <15 years was also associated with higher rates of prescribing (β = 11.0,
p < 0.001). The GP practices located in Northern LCG (β = 103.8, p < 0.001), Western LCG
(β = 125.3, p < 0.001), and Belfast LCG (β = 72.9, p = 0.001) prescribed, on average, more
antibacterial drugs than GP practices in Southern LCG. The practice size (β = 0.64, p = 0.91)
had no effect on prescribing rates.
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Given the interaction terms in our model, we observed that the effect of time on antibi-
otic prescribing rates decreased by 0.007 items/1000 patients for every one-unit increase in
MDM rank (β = −0.007, p = 0.03), meaning that the overall decrease in antibacterial drug
prescriptions over time was larger in less deprived areas. Although higher percentage of
the population aged ≥65 years was, on average, associated with higher rates of prescrib-
ing, this trend was becoming less significant over time (β = −0.38, p = 0.008). The effect
of time on prescribing was also higher by 5.3 items/1000 patients (p = 0.003) for urban
practices compared to rural practices. Finally, the change in the level of prescribing in
GP practices located in Northern LCG, Western LCG, and South Eastern LCG was higher
every year by 6.7 items/1000 patients (p = 0.003), 8.9 items/1000 patients (p < 0.001), and
9.7 items/1000 patients (p < 0.001), respectively, than prescribing in Southern LCG.
To further validate the robustness of the main findings, we implemented a sensitivity
analysis to measure the potential impact of the COVID-19 pandemic on the association
between different demographic, geographic, socioeconomic factors and antibiotic pre-
scribing rates. Accordingly, a multilevel modelling analysis was conducted using only
antibiotic prescription data from the period 2014–2019 (and thus, excluding the data col-
lected during the COVID-19 pandemic), and the results compared with the findings of
the main analysis based on the antibiotic prescription data from the period 2014–2020.
The results of sensitivity analyses were consistent with those from the primary analysis.
On average, urban practices prescribed antibiotics less than rural practices (β = −66.4,
p < 0.001), and this difference was becoming more significant over time (β = 6.3, p = 0.001).
Furthermore, lower levels of antibiotic prescribing were associated with GP practices in
less deprived areas (β = −0.1, p = 0.007) as well as those in areas with higher percentages of
the population aged ≥65 (β = 10.1, p < 0.001) and <15 years (β = 11.3, p < 0.001). Although
higher percentage of the population aged ≥65 years was, on average, associated with
higher antibiotic prescribing, this trend was becoming less significant over time (β = −0.42,
p = 0.006). The GP practices located in Northern LCG (β = 104.7, p < 0.001), Western LCG
(β = 128.9, p < 0.001), and Belfast LCG (β = 73.6, p = 0.002) prescribed, on average, more
antibacterial drugs than GP practices in Southern LCG. Moreover, the change in the level
of prescribing in GP practices located in Northern LCG, Western LCG, and South Eastern
LCG was higher every year by 6.3 items/1000 patients (p = 0.009), 7.2 items/1000 patients
(p = 0.007), and 7.5 items/1000 patients (p = 0.006), respectively, than prescribing in South-
ern LCG. The practice size (β = 0.36, p = 0.95) had no effect on antibiotic prescribing. Finally,
for every one-year increase, the standardised number of prescribed antibiotics decreased
by 28.4 items/1000 patients (p < 0.001). The annual rate of change in prescribing over
the period 2014–2019 was therefore substantially lower than the 40.3 items/1000 patients
decrease for every one-year increase in the period 2014–2020, highlighting the potential
impact of the COVID-19 pandemic on the overall reduction in antibacterial prescribing.
4. Discussion
This is the first study to investigate determinants of antibiotic prescribing in Northern
Ireland. We implemented a well-validated multilevel modelling approach allowing us to
examine antibiotic prescribing practices in a systematic way and control for the potential
confounding effects of practice, demographic, geographical, and socioeconomic factors. We
showed a significant impact of several characteristics including rurality, deprivation, LCG,
and percentage of the population aged ≥65 and <15 years on the standardised number of
prescribed antibacterial drugs. We found that rural practices, practices in more deprived
areas and those located in SOAs with high percentages of the population aged ≥65 and
<15 years were associated with higher levels of antibiotic prescribing. In addition, we
observed a large variation in antibiotic prescribing between LCGs and a significant effect of
time on prescribing, given changes in MDM rank, rurality, and LCGs categories.
Our results showing that GP practices located in areas with a higher level of depri-
vation were associated with higher levels of antibiotic prescribing are in line with other
studies [13–15]. Wise [13] reported a 20% difference in prescribing levels between the
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least and most deprived areas in England. More recently, Thomson et al. [32] showed
that the most deprived areas of England had the highest levels of antibiotic prescribing.
Covvey et al. [14]. demonstrated that the overall antibiotic prescription rates in Scotland
were 36.5% higher in the most deprived quintile compared to the least deprived quintile,
with the prescribing rates of 2.49 items and 1.58 items per 1000 patients per day, respectively.
The analysis by Butler et al. [15] based on the data from 240 GP practices in Wales, showed
an increase in the rate of antibiotic resistance, with levels 6% higher in the most deprived
quartile. In Northern Ireland, higher rates of antibacterial prescribing were previously
shown to be linked to increased deprivation, but this relationship was not adjusted for
other covariates [33]. Given the practice size, previous studies reported no associations
between single-handed practices and antibiotic prescribing rates [17,34,35].
Interestingly, our results also indicated that prescribing of antibacterial drugs de-
creased faster in areas with a lower level of deprivation. Furthermore, the observed
patterns of antibiotic use by rurality and age were consistent with other studies [17,36–38].
For example, Curtis et al. [17] reported that GP practices with a higher proportion of pa-
tients >65 and <18 years old were more likely to prescribe more antibiotics. A study by
Bou-Antoun et al. [39] found that antibiotic prescription rate per 1000 consultations was
highest in adults aged 65 and older. We also observed a large between-practice variation in
prescribing that was noted previously [16].
Our study has several limitations. First, we only assessed the changes and variation of
antibiotic prescribing, but we did not evaluate the appropriateness of prescribing. Second,
we acknowledge that characteristics, i.e., deprivation and demographics, that apply at
an area level, do not necessarily apply at an individual practice level. Furthermore, our
investigation was limited by the unavailability of GP practice-level datasets on patient
(e.g., comorbidities) and GP characteristics (e.g., age, gender, training, workload, and
attitude). The inclusion of GP characteristics could potentially further improve the fit of
our model given the fact that significant between-GP practice variation in prescribing was
previously related to intra-physician variability [16]. It is also possible that higher antibiotic
prescribing observed in some GP practices was associated with higher proportions of
registered patients being more susceptible to bacterial infections. Previous work showed
that increased susceptibility for developing a bacterial infection, including measles [40], and
tuberculosis [40], can be linked to nutritional deficiency [41], smoking [42], and reduced
vaccination uptake [43].
The observed decrease in antibiotic prescribing in Northern Ireland has likely been
influenced by the implementation of antimicrobial guidance for primary care that comple-
ments the work of HSC Trusts in reducing antimicrobial resistance [44]. Furthermore, the
reduction in antibiotic prescribing might have been related to the employment of a large
number of practice-based pharmacists in recent years who advise on antimicrobial pre-
scribing, in particular, on the dose and duration of long-term and repeat prescriptions [10].
As a part of the Pharmaceutical Clinical Effectiveness (PCE) programme, GP surgeries
are also supported by HSCB pharmacy advisors who provide GPs with practice-specific
feedback (COMPASS reports) indicating not only how their prescribing rates differ from
other practices but also identifying potential efficiencies [45]. Despite the reduction in
antibiotic consumption over time, there is still large variability in prescribing among GP
practices in Northern Ireland. This variation can be partially explained by demographic,
geographical, and socioeconomic characteristics. Any antibiotic prescribing targets should
therefore account for local factors so that GP practices are not inappropriately penalised.
5. Conclusions
Our findings contribute to the debate on determinants of antibiotic prescribing in
primary care and provide actionable insights to policy makers responsible for antimicro-
bial stewardship and public health campaigns. Indicators of antibiotic prescribing used
in NI primary care do not incorporate the provider or population characteristics. The
currently used STAR-PU measure only adjusts for the age and gender composition of
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the NI population. Our results indicate the need for further adjustment for other fac-
tors to ensure unbiased comparison between GP practices, and to target interventions
appropriately. Future research will focus on conducting an individual-level analysis by
linking individual clinical, microbiology, and prescribing records to assess the extent to
which prescribing conformed to local guidelines. Specifically, we will assess how the rates
of antibiotic prescription deviate from the prescribing guidelines, based on the type of
recorded infection.
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